StreetAlpha.app
Home › Stocks › SOLV

Solventum Corp (SOLV)

Healthcare
$86.09
▼ −2.89%
LAST CLOSE · NOV 17

Solventum makes medical, dental and health information products for hospitals, clinics and dental practices. It last closed at $86.09 on Nov 17, down 2.89% on the day. SOLV last reported earnings on Thu, Nov 5, 2026. The average 12-month price target from 2 analysts is $102.50 (+19.1% from the last close), with a high of $110.00 and a low of $95.00. In the past 30 days there were 3 dark pool prints totaling $2.2M, the largest $864K.

AI Auto Pilots
Is SOLV in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$8.2B
−2.8% vs a year ago
Net income
$156.0M
−89.8% vs a year ago
EPS (diluted)
$0.89
−89.8% vs a year ago
Free cash flow
$0
0.0% margin
Valuation
Market cap
$14.6B
169.7M shares
P/E
96.7
Price over 12 month EPS
Price to sales
1.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$451.0M
At Sep 30
Debt
$5.1B
At Sep 30
Shareholder equity
$4.8B
Shares outstanding
169.7M
At Oct 31
CEOhttp://www.wikidata.org/.well-known/genid/c6676296959e160da6bc22e3f7ae3d21
Employees20,000 (2025)
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2022: $8.1B$8.1BFY2022FY2023: $8.2B$8.2BFY2023FY2024: $8.3B$8.3BFY2024FY2025: $8.3B$8.3BFY2025

From SOLV's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · After the close (AMC)
Reported EPS
$1.45
vs $1.34 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±6.9%
Priced in before that report
Analyst consensus
1 Buy · 1 Hold
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy · 1 Hold
2firms
1 Buy1 Hold0 Sell
Only 2 firms rated SOLV in the past 90 days, not enough for a consensus
Average 12-month target
$102.50
▲ 19.1% upside

Based on 2 analysts who set a price target on SOLV in the past 90 days. The average target is $102.50, with a high of $110.00 and a low of $95.00, compared with the last close of $86.09.

Low $95.00Avg $102.50High $110.00
Blue marker: last close $86.09
Highest target$110.00
Average target$102.50
Lowest target$95.00
Latest rating changes
Wells FargoMaintained
Nov 6Hold$95
Piper SandlerTarget raised
Nov 6Buy$105 → $110
UBSTarget raised
Aug 6Buy$95 → $101
Piper SandlerMaintained
Aug 6Buy$105
WedbushTarget raised
Aug 6Buy$94 → $101
DateFirmActionRatingPrice target
Nov 6Wells FargoMaintainedHold$95
Nov 6Piper SandlerTarget raisedBuy$105 → $110
Aug 6UBSTarget raisedBuy$95 → $101
Aug 6Piper SandlerMaintainedBuy$105
Aug 6WedbushTarget raisedBuy$94 → $101
Loading…

Technical Analysis

SOLV · as of the Nov 17 close · updated after every close
Moving sideways

The stock is 1% below its 20 day and 1% below its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is neutral (RSI 46). The nearest support is the 100 day average at $85.80, and the nearest resistance the 20 day average at $86.65.

Short trendNeutral
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 3.1%/day
Key levels
$94.1652 week high+9.4%
$87.97Pivot R1+2.2%
$87.87Swing high (Oct 22)+2.1%
$87.3750 day average+1.5%
$87.01Pivot+1.1%
$86.6520 day average+0.7%
$86.09Last close
$85.80100 day average−0.3%
$85.12Pivot S1−1.1%
$85.04Swing low (Oct 19)−1.2%
$78.95200 day average−8.3%
$62.3852 week low−27.5%
Indicators
RSI (14)46.50Middle of its rangeNeutral
MACD0.48Above its signal lineBullish
Stochastic58.8Middle of its rangeNeutral
ADX (14)13.9No clear trend
Williams %R-56.3Oversold below −80, overbought above −20Neutral
CCI (20)8.2Oversold below −100, overbought above 100Neutral
Rate of change+1.6%Change over 10 sessionsBullish
ATR (14)$2.69Typical daily range, 3.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for SOLV

What happened before

See how SOLV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in SOLV in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
3
Notional
$2.2M
Largest print
$864K
Loading…

SOLV Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼329 buying vs 387 selling
  • ●Held by funds -0.4 pts
  • ●Funds holding +7
  • ●Superinvestors: 2 added, 2 cut
  • ▲Put/call 0.35 to 0.02
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding895888+0.8%
In funds' top 10810−20.0%
Held by funds75.0%75.4%−0.4 pts
New / increased89 / 240108 / 253−8.9%
Reduced / sold out312 / 75283 / 111−1.8%
Put/call ratio0.020.35−93.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SOLV institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SOLV Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$596.7M
4.1% of value
Shares outstanding, 12 months
−2.1%
Fewer shares
Last quarter
$48.4M
Sep 2026
Avg price paid, last quarter
$84.87
571K shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $287.9M
Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $0Sep 2025: $0Dec 2025: $0Mar 2026: $66.9M, average price $72.53Jun 2026: $287.9M, average price $74.71Sep 2026: $48.4M, average price $84.87
Mar 2024Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SOLV is in one of them and how their past SOLV trades turned out.

SOLV in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SOLV in an article yet. Here's the latest on the wider market.

SOLV Congress Trades

All congress trades →
Trades, 12 months
15
Buys
9
60%
Sells
6
40%
People
6
Last filed Aug 5
Who traded SOLV · since 2024
Latest 5 filings of 22
$1K – $15KTraded May 3, 2024Filed Aug 5, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$15K – $50KTraded May 11, 2026Filed Jul 1, 2026
$1K – $15KTraded May 27, 2026Filed Jun 9, 2026
$1K – $15KTraded May 1, 2026Filed Jun 9, 2026
PersonTypeAmountTradedFiledDelay
Tommy TubervilleR · ALSell$1K – $15KMay 3, 2024Aug 5, 2026824 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Donald J TrumpExecutive branchBuy$15K – $50KMay 11, 2026Jul 1, 202651 d
Ro KhannaD · CABuy$1K – $15KMay 27, 2026Jun 9, 202613 d
Ro KhannaD · CABuy$1K – $15KMay 1, 2026Jun 9, 202639 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Solventum

Solventum makes medical, dental and health information products. Its medical business sells wound care, surgical supplies and infection prevention products. Its dental unit offers orthodontic brackets, aligners, and restorative cements and bonding agents. A third business provides software that helps health systems with physician documentation, coding and billing. Its customers range from multidisciplinary hospitals to local clinics and dental practices, and the company is based in Eagan, Minnesota.

Headquarters
Eagan, MN
Founded
2024